Haemonetics Corporation is a healthcare company that specializes in medical products and solutions primarily for blood and plasma collection. It operates through three segments: Plasma (approximately 40% of revenue), Blood Center (about 35%), and Hospital (around 25%). The company generates revenue from the sale of automated plasma collection devices, blood component collection systems, and hospital products, including hemostasis analyzers and related software. Factors supporting its endurance include a growing demand for blood and plasma products and technological advancements in medical devices. However, competition and regulatory challenges in the healthcare sector could limit its growth potential.
—
Haemonetics Corporation is a healthcare company that specializes in medical products and solutions primarily for blood and plasma collection. It operates through three segments: Plasma (approximately 40% of revenue), Blood Center (about 35%), and Hospital (around 25%). The company generates revenue from the sale of automated plasma collection devices, blood component collection systems, and hospital products, including hemostasis analyzers and related software. Factors supporting its endurance include a growing demand for blood and plasma products and technological advancements in medical devices. However, competition and regulatory challenges in the healthcare sector could limit its growth potential.
—
Daily adjusted close
Haemonetics Corporation is a healthcare company that specializes in medical products and solutions primarily for blood and plasma collection. It operates through three segments: Plasma (approximately 40% of revenue), Blood Center (about 35%), and Hospital (around 25%). The company generates revenue from the sale of automated plasma collection devices, blood component collection systems, and hospital products, including hemostasis analyzers and related software. Factors supporting its endurance include a growing demand for blood and plasma products and technological advancements in medical devices. However, competition and regulatory challenges in the healthcare sector could limit its growth potential.